Skip to main content
. Author manuscript; available in PMC: 2008 Dec 5.
Published in final edited form as: Anesth Analg. 2007 May;104(5):1179–contents. doi: 10.1213/01.ane.0000260267.71185.73

Figure 6.

Figure 6

Increased bcl-2 protein levels in 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP)- treated neurons exposed to 2 h oxygen–glucose deprivation (OGD) and 30 min, 3 or 6 h of recovery. Data are compiled from three separate experiments for each exposure and treatment condition. Protein levels are normalized to β-actin. *P < 0.05 from PPBP treatment at 6 h.